Biological Dentistry Under the Microscope: What the Evidence Says About Fluoride, Amalgam, Root Canals, PRF, Ozone and Jawbone Cavitations
Dentistry has always lived at the intersection of biology and engineering. We remove infection, rebuild damaged structures, introduce foreign materials into the body and increasingly recognize that what happens in the mouth does not necessarily stay in the mouth. Yet few labels generate more heat today than “biological dentistry.” To supporters, it represents dentistry finally considering the whole patient. To critics, it is a marketing umbrella covering treatments that range from reasonable to unproven.
Both descriptions contain some truth. Neither is particularly useful in the operatory.
The better question is not whether biological dentistry is right or wrong. It is whether a specific diagnosis, material or treatment improves outcomes for a specific patient compared with the alternatives. That standard should apply equally to amalgam, composites, fluoride, root canals, implants, platelet rich fibrin, ozone and jawbone cavitations.
This is where the debate becomes much more interesting.
Biological Dentistry Is Not One Thing
Biological dentistry is not a recognized dental specialty. It is better understood as a philosophy emphasizing biocompatibility, individual variation and the relationship between oral and systemic health. Some of its principles are hardly controversial. Medical history matters. Nutrition and medications matter. Materials can produce adverse reactions in susceptible patients. Preserving tooth structure is desirable. Chronic oral infection deserves treatment. Patient preferences belong in treatment planning.
In fact, these principles fit comfortably within the ADA’s definition of evidence based dentistry, which combines the best available scientific evidence with clinical expertise and the patient’s medical and oral condition, needs and preferences.
The trouble begins when that broad philosophy becomes evidence for specific claims.
Saying the mouth is connected to the body does not prove that individual teeth correspond to distant organs through energetic meridians. Demonstrating persistent apical periodontitis after some root canals does not establish that root canal treated teeth cause cancer. Finding an unusual area on CBCT does not prove that the area is diseased bone requiring surgery.
Biological plausibility is the beginning of an investigation, not the end of one.
Fluoride Is More Complicated Than Either Side Admits
Few dental subjects demonstrate this better than fluoride.
The simplistic arguments are familiar. One side says fluoride prevents cavities and therefore the matter is settled. The other says fluoride is neurotoxic and Europe has rejected it.
Current evidence supports neither extreme.
The 2024 Cochrane review found that community water fluoridation historically produced substantial reductions in childhood caries. But much of that evidence came from the era before fluoride toothpaste became ubiquitous. In more contemporary studies, the additional benefit appears smaller and considerably less certain. Evidence for permanent teeth was particularly uncertain, and the review did not establish an effect on adult caries.
That does not mean fluoridation does nothing. It means its incremental benefit in a modern population already exposed to fluoride toothpaste may be smaller than historical estimates suggest.
The safety discussion is equally nuanced. The National Toxicology Program concluded with moderate confidence that higher fluoride exposure is associated with lower IQ in children, with the strongest evidence involving exposures around or above 1.5 mg/L. Its subsequent meta-analysis reinforced the association between increasing fluoride exposure and lower childhood IQ.
But the NTP explicitly says available evidence is insufficient to determine whether drinking water at approximately 0.7 mg/L, the concentration recommended for U.S. community fluoridation, negatively affects children’s IQ.
Meanwhile, England’s 2026 health monitoring report found lower childhood caries and fewer caries related hospital extractions in fluoridated communities, with particularly meaningful benefits in disadvantaged populations. It found no association with the childhood cognitive outcomes it examined.
The practical lesson is simple. Dose matters. Exposure matters. Population matters. “Fluoride works” does not prove every exposure is harmless, and evidence of potential neurodevelopmental effects at higher exposure does not prove that 0.7 mg/L causes neurological injury.
That unresolved space is where good science belongs.
Amalgam Contains Mercury. What Follows From That?
Amalgam presents a similar reasoning trap.
The FDA acknowledges that dental amalgam is approximately 50 percent elemental mercury by weight and releases measurable mercury vapor. Mercury can accumulate in tissues, and sufficiently high mercury exposure is neurotoxic.
Those are facts.
The next sentence is where evidence becomes essential.
The FDA says the majority of available evidence has not demonstrated harmful health effects from amalgam exposure in the general population. At the same time, it recommends avoiding new amalgam when possible and clinically appropriate in potentially vulnerable patients, including pregnant women, young children and people with certain neurological conditions, impaired kidney function or known mercury sensitivity.
Most importantly for everyday dentistry, the FDA does not recommend prophylactically removing intact amalgam restorations. Removal temporarily increases mercury exposure and sacrifices additional tooth structure.
The ADA remains more reassuring about amalgam, describing it in 2026 as safe, durable and affordable when clinically appropriate. Yet amalgam is clearly disappearing. Composites have replaced much of its historical use, environmental concerns surrounding mercury have intensified, the Indian Health Service plans to discontinue amalgam beginning in 2027, and international policy is moving toward a broad global phaseout.
Dentists should not confuse that policy trend with proof that existing amalgams cause systemic disease.
For the patient asking, “Should I have all my silver fillings removed because they contain mercury?” the evidence supports a much more useful conversation. Yes, amalgam contains mercury. Yes, alternatives exist. Yes, individual circumstances matter. No, current evidence does not establish that routinely removing sound amalgams improves systemic health.
That is informed consent without either reassurance theater or fear marketing.
Root Canals and the Difference Between Failure and Causation
Root canals generate perhaps the fiercest biological dentistry arguments because there is a legitimate biological issue buried beneath an enormous causal leap.
Root canal treatment does not succeed biologically in every tooth. Persistent apical periodontitis, missed anatomy, residual microorganisms, coronal leakage and reinfection are real. A tooth can be asymptomatic and still demonstrate persistent apical disease.
The IAOMT’s 2026 review emphasizes this problem and argues that conventional two dimensional radiographs may underestimate persistent disease compared with CBCT. It also points to research associating apical periodontitis with cardiovascular, metabolic and other systemic inflammatory conditions.
Those are legitimate questions.
The leap occurs when persistent disease in some teeth becomes evidence that root canal treated teeth as a category cause systemic illness and should therefore be removed.
The American Association of Endodontists maintains that there is no valid scientific evidence establishing that properly treated endodontic teeth cause systemic disease. Its updated 2026 materials actually acknowledge growing research into relationships between endodontic infection, systemic inflammation and metabolism. The disagreement is therefore subtler than it appears.
Both sides recognize infection.
Both recognize apical periodontitis.
Both recognize that treatment can fail.
The real dispute concerns what can be inferred from those observations.
Association between apical periodontitis and cardiovascular disease does not establish that root canal treatment caused the cardiovascular disease. Nor does it demonstrate that extracting an otherwise maintainable endodontically treated tooth will improve the patient’s systemic outcome.
That last question is particularly important because extraction has consequences. It may initiate grafting, implant placement, prosthetic treatment, additional surgery and substantial expense. Extraction is not the biologically neutral alternative to endodontics.
For the practicing dentist, a better question than “Are root canals safe?” is, “Did this particular treatment successfully control this patient’s disease?”
That question can actually guide treatment.
When CBCT Finds Something, What Exactly Have We Found?
Jawbone cavitations, NICO and FDOJ illustrate another challenge created by modern technology. The more sensitively we image the human body, the more abnormalities we find.
A 2022 systematic review found the NICO and FDOJ literature methodologically poor, with no randomized controlled trials and no reliable diagnostic gold standard. The authors concluded that these conditions could not yet be diagnosed safely, reliably and reproducibly based on the available evidence.
That does not prove every phenomenon described as a jawbone cavitation is imaginary.
A fascinating 2026 review introduced the term “Covered Socket Residuum,” or CSR, for certain nonmineralized areas found beneath apparently healed extraction sites. The authors propose that some of these findings may represent incomplete but physiological socket ossification rather than osteonecrosis or chronic infection.
That possibility changes the clinical conversation.
A radiographic finding is an observation. A diagnosis is an interpretation. An indication for surgery requires another evidentiary step.
The ADA’s radiographic guidance reinforces exactly this principle. Radiographs are adjuncts to diagnosis, not diagnoses themselves. CBCT should be used when the additional three dimensional information is clinically necessary, not simply because the machine is available.
This matters financially and ethically. Once a patient has been told that a CBCT reveals “dead bone” or a hidden source of systemic illness, declining surgery becomes psychologically difficult. Diagnostic language itself can create case acceptance.
If the diagnosis is uncertain, the language should communicate that uncertainty.
PRF Shows How an Alternative Becomes Evidence Based
Platelet rich fibrin provides a useful counterexample to the claim that conventional dentistry simply rejects anything unconventional.
PRF sounds thoroughly biological. Draw the patient’s blood, concentrate platelets and fibrin, and place the resulting matrix into a surgical site to support healing.
The important difference is that researchers tested it.
A systematic review of autologous platelet concentrates after mandibular third molar extraction included 59 randomized controlled trials, 45 involving leukocyte and platelet rich fibrin. Overall, the studies favored platelet concentrates for outcomes including pain, analgesic consumption, swelling, trismus, dry socket and aspects of soft tissue and bone healing. The literature was heterogeneous and carried substantial risk of bias, so the precise magnitude of benefit remains uncertain.
A separate 2024 systematic review and meta-analysis examining PRF specifically pooled 33 randomized trials involving more than 2,200 extraction sockets. PRF was associated with reductions in pain, swelling, trismus and dry socket, along with evidence of improved bone healing. Soft tissue benefits were less certain.
PRF therefore has not become credible because it is natural. It has become increasingly credible because measurable outcomes have been compared in controlled trials.
That distinction should be the model for every emerging treatment.
Ozone Is Promising, but Earlier on the Evidence Curve
Ozone occupies a different position.
Its antimicrobial mechanism is biologically plausible, and clinical research exists. A 2024 systematic review of ozone for caries in primary teeth found seven eligible clinical studies. Results suggested that gaseous ozone could produce clinical and antibacterial outcomes comparable with other interventions, with good patient acceptance and no adverse effects reported in the included studies.
That could have real clinical value in young or poorly cooperative children where minimally invasive treatment is especially desirable.
But four of the seven studies were at high risk of bias, protocols varied substantially, and the investigators could not perform a meaningful meta-analysis.
The appropriate conclusion is therefore neither “ozone is quackery” nor “ozone works.”
It is promising, indication dependent and incompletely established.
PRF, ozone and tooth meridians may all appear in conversations about biological dentistry, but scientifically they do not belong in the same bucket. One has dozens of randomized trials. Another has an encouraging but limited clinical literature. The third lacks comparable evidence establishing the claimed diagnostic relationships.
Labels obscure these differences.
Tooth Regeneration Shows What Real Disruption Looks Like
Perhaps the most extraordinary biological development has nothing to do with detoxification or meridians.
Researchers are attempting to regenerate teeth.
Experimental work targeting USAG-1, a protein involved in regulating tooth development, has restored tooth formation in animal models. Researchers have developed TRG035, a humanized monoclonal antibody targeting USAG-1, for potential treatment of congenital tooth agenesis.
A 2026 paper describes sophisticated MRI and imaging biomarkers intended to identify developing tooth structures before conventional radiographs can see mineralized teeth. That could allow researchers to determine much earlier whether experimental therapy has restarted tooth development rather than waiting years for eruption.
But the distinction between discovery and dentistry matters. The paper does not demonstrate that dentists can currently administer a drug and predictably regenerate functional human permanent teeth.
If controlled human trials eventually show that a medication can cause a missing permanent tooth to develop, erupt, integrate with the periodontium and function normally, restorative dentistry could change profoundly.
For now, it remains experimental.
This is what genuine scientific openness looks like. The idea is extraordinary. Researchers do not therefore lower the evidentiary bar. They raise it.
Evidence Based Dentistry Is Designed to Change
Dentists sometimes interpret changing recommendations as proof that professional organizations cannot be trusted. The history of radiographic shielding demonstrates why that conclusion is backwards.
For generations, patients expected a lead apron before dental X-rays. In 2024, the ADA recommended discontinuing routine lead abdominal and thyroid shielding, including for children and pregnant patients. Modern digital imaging, appropriate collimation and optimized exposure settings provide more meaningful radiation reduction, while misplaced shielding can obscure anatomy and lead to retakes.
The lesson is not that radiation suddenly became harmless. It is that better evidence and better technology changed the risk benefit calculation.
That is exactly what evidence based dentistry is supposed to do.
Professional consensus deserves weight because it usually reflects accumulated evidence and experience. But consensus is not permanent truth. When better evidence arrives, recommendations should change.
The opposite error is equally dangerous. The fact that dentistry changed its mind about lead aprons does not prove that an unrelated unconventional treatment must eventually be vindicated. Every claim must earn its own evidence.
Follow the Evidence and the Incentives
One of the least useful arguments in these debates is motive attribution.
Endodontists make money performing root canals. Implant dentists make money placing implants. Manufacturers make money selling restorative materials. Biological dentists may make money removing amalgams, extracting root canal treated teeth, treating suspected cavitations, selling supplements or placing ceramic implants.
None of those facts determines whether a treatment works.
Financial incentives deserve disclosure and scrutiny in every direction, including research funded by companies developing promising therapies. But conflicts of interest are reasons to examine evidence more carefully, not shortcuts for deciding whether evidence is true.
The same applies to anecdotal success. A patient who reports dramatic improvement after amalgam removal or cavitation surgery deserves to be heard. That experience can generate an important hypothesis. It cannot tell us by itself whether the dental procedure caused the improvement, whether another intervention was responsible, or whether similar patients would benefit on average.
That is why comparison groups exist.
A Better Standard for Dentaltown
Dentistry does not need another tribal war between “traditional” and “biological” dentists. It needs better questions.
When someone proposes an unconventional treatment, ask what diagnosis is being treated, how that diagnosis is validated, what outcome is being measured, what happens without treatment, what the alternatives are, how large the benefit is, what harms occur, whether independent investigators have reproduced the result and what evidence would prove the hypothesis wrong.
Apply exactly the same questions to conventional dentistry.
New ideas should never be rejected simply because they challenge conventional dentistry, but neither should they be accepted simply because they challenge it. They should be compared with existing treatments and judged by whether they measurably improve patient outcomes without introducing disproportionate harm.
That standard protects innovators from dogmatism and patients from pseudoscience.
Dentaltown can be especially valuable here because dentists need somewhere to discuss uncomfortable ideas without turning disagreement into personal attack. Calling someone a quack is not a rebuttal. Calling critics closed minded is not evidence. The strongest scientific response remains much simpler.
Show me the data.
Biological dentistry may ultimately contribute valuable ideas to mainstream care. Some already appear to be making that transition. Others may fail when properly tested. That is not a weakness of science. That is how science separates promising ideas from persuasive stories.
The best culture dentistry could build is therefore neither pro biological nor anti biological. It is radically open to questions and radically demanding about answers. What would change your mind?
Join the Conversation!